Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Novartis
Accenture
Argus Health
Citi
Julphar
Boehringer Ingelheim
Harvard Business School
Cipla

Generated: January 21, 2018

DrugPatentWatch Database Preview

REMSED Drug Profile

« Back to Dashboard

When do Remsed patents expire, and when can generic versions of Remsed launch?

Remsed is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in REMSED is promethazine hydrochloride. There are twelve drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
Drug patent expirations by year for REMSED
Medical Subject Heading (MeSH) Categories for REMSED

US Patents and Regulatory Information for REMSED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb REMSED promethazine hydrochloride TABLET;ORAL 083176-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb REMSED promethazine hydrochloride TABLET;ORAL 083176-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Citi
Express Scripts
Deloitte
Harvard Business School
Colorcon
Boehringer Ingelheim
Novartis
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot